Boris Johnson has confirmed that a deal had been done with pharmaceutical giant GlaxoSmithKline (GSK) to provide "fill and finish" capacity at its Barnard Castle facility in the North East of England for the Novavax vaccine.

The Prime Minister told a Downing Street news conference the collaboration will be "giving us between 50 and 60 million doses of UK-made vaccine", subject to approval from regulators.

He also stressed the benefits of exercise to build the UK's "resilience" to the virus, saying "I am personally thrilled that I will be able to play tennis, for instance".

"Without being remotely preachy, I do hope that we can take advantage of this moment and the beautiful weather to play sport, to take exercise, to have fun and build our national resilience in that way too."

Read more here: https://www.telegraph.co.uk/global-health/science-and-disease/coronavirus-news-lockdown-rule-6-covid-astrazeneca-vaccine-cases/

Subscribe to The Telegraph on YouTube ► https://bit.ly/3idrdLH

Get the latest headlines: https://www.telegraph.co.uk/

Telegraph.co.uk and YouTube.com/TelegraphTV are websites of The Telegraph, the UK's best-selling quality daily newspaper providing news and analysis on UK and world events, business, sport, lifestyle and culture.

#BorisJohnson #Covid #Novavax